semaglutide
Obesity Treatment Shock GLP‑1 Cuts 30% Drinks
Semaglutide, a GLP-1 agonist, can lower heavy-drinking days by about 30% while also promoting meaningful weight loss. Clinical trials show the drug amplifies satiety signals and dampens reward pathways, offering clinicians a single prescription that tackles both excess weight and alcohol cravings. Medical Disclaimer: This article is for informational purposes